Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Publication Date: June 7, 2023
Last Updated: June 7, 2023

Highlights

All newly diagnosed patients with breast cancer must have a HER2 test performed. Patients who then develop metastatic disease must have a HER2 test performed in a metastatic site, if tissue sample is available.

Overview

Title

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Authoring Organizations